Investors’ data
Latest news
- July 12, 2010
THALLION ANNOUNCES 2010 SECOND QUARTER RESULTS
- June 24, 2010
THALLION ELIMINATES LONG-TERM LEASE OBLIGATION
- June 16, 2010
THALLION PHARMACEUTICALS RECEIVES ARBITRATION DECISION ON TLN-232 LICENSE AGREEMENT
Documentation
Corporate Governance
Thallion Pharmaceutical Inc. and its Board of Directors believe that transparent and sound corporate governance practices are critical to the Company’s long-term success.
The Board believes that the Company’s corporate governance practices are well aligned with the recommendations contained in the various applicable guidelines and regulations issued by the Toronto Stock Exchange (TSX Guidelines) and other securities regulators.
For further information, please refer to our corporate profile on SEDAR.